https://www.indianpharmapost.com/cipla-posts-q3-fy24-consolidated-pat-at-rs-105590-cr-151792024-01-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/sagimet-biosciences-announces-positive-topline-results-from-phase-2b-trial-of-denifanstat-151812024-01-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/ema-grants-odd-to-gc-biopharmas-treatment-for-sanfilippo-syndrome-151822024-01-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/european-commission-grants-odd-to-ns-229-for-treatment-of-eosinophilic-granulomatosis-151832024-01-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/granules-india-posts-q3-fy24-consolidated-pat-at-rs-12565-cr-151842024-01-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-life-sciences-posts-q3-fy24-pat-at-rs-11876-cr-151852024-01-23T00:00:00+05:30always0.9